News

By Dennis Thompson HealthDay ReporterTUESDAY, June 24, 2025 (HealthDay News) — A new Chinese-developed GLP-1 weight loss drug could prove a new competitor to blockbuster drugs Ozempic /Wegovy and ...
Key Takeaways A new drug combo can help prevent muscle loss on GLP-1 drugsCombining bimagrumab with semaglutide caused 93% of weight loss to come from fat aloneBy comparison, about 72% of weight loss ...
Novo Nordisk has launched Wegovy, a once-weekly weight-loss injection, in India. The drug aims to manage obesity and reduce ...
Novo Nordisk launches its FDA-approved weight-loss drug Wegovy in India, rivaling Eli Lilly’s Mounjaro, as obesity and ...
Take a good look in the mirror — not just at your reflection, but at what it might be telling you. That belly bulge, which ...
Danish pharma giant Novo Nordisk on Tuesday launched its blockbuster weight loss drug Wegovy as a once-a-week injection in ...